The current state of bariatric endoscopy

Area of Science:

• Medical Science
• Gastroenterology
• Endocrinology

Background:

• Obesity is a global health crisis with increasing prevalence.
• Traditional bariatric surgery has limitations, driving the need for less invasive options.

Purpose of the Study:

• To review the current landscape of endoscopic bariatric and metabolic treatments (EBMTs).
• To detail FDA-approved and investigational endoscopic therapies for obesity.

Main Methods:

• Comprehensive literature review of endoscopic bariatric and metabolic treatments.
• Focus on US Food and Drug Administration (FDA) approved devices and emerging technologies.

Main Results:

• Details FDA-approved intragastric balloons (IGBs), aspiration therapy, and tissue apposition devices.
• Discusses non-FDA approved IGBs, endoluminal bypass liners, duodenal resurfacing, and anastomosis devices.

Conclusions:

• Endoscopic bariatric and metabolic treatments represent a growing field in obesity management.
• A range of endoscopic options, both approved and investigational, are available for patient care.